IMV Inc. (IMVIF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -35.52 Million USD | 5.0% |
| 2021 | -36.41 Million USD | -13.82% |
| 2020 | -28.33 Million CAD | -58.93% |
| 2019 | -21.94 Million CAD | -39.08% |
| 2018 | -15.77 Million USD | -62.06% |
| 2017 | -9.14 Million USD | -61.18% |
| 2016 | -6.04 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 Q4 | -8.61 Million USD | 6.58% |
| 2022 FY | - USD | 5.0% |
| 2022 Q1 | -10.57 Million USD | 7.0% |
| 2022 Q2 | -10.36 Million USD | 2.03% |
| 2022 Q3 | -9.21 Million USD | 11.02% |
| 2021 Q3 | -10.69 Million USD | 0.0% |
| 2021 FY | - USD | -13.82% |
| 2021 Q4 | -11.37 Million USD | -6.28% |
| 2020 FY | - CAD | -58.93% |
| 2019 FY | - CAD | -39.08% |
| 2018 FY | - USD | -62.06% |
| 2017 FY | - USD | -61.18% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 49.992% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -499.156% |
| SQZ Biotechnologies Company | -64.14 Million USD | 44.617% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -104.51% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 137.776% |
| Mesoblast Limited | -62.38 Million USD | 43.062% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -2212.647% |
| Genus plc | 73.7 Million USD | 148.2% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -437.296% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -901.506% |
| Marizyme, Inc. | -34.28 Million USD | -3.623% |
| ContraFect Corporation | -64.99 Million USD | 45.348% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -304.963% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -684.84% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -2434.113% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -1243.32% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -1428.664% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -6757.189% |
| Accustem Sciences Inc. | -3.74 Million USD | -848.196% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 26.341% |
| EV Biologics, Inc. | -1.26 Million USD | -2703.449% |
| Q BioMed Inc. | -617.62 Thousand USD | -5651.584% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 1094.496% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -5517.182% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -1454.982% |
| Biomind Labs Inc. | -1.03 Million USD | -3333.708% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 459.658% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -396.048% |
| Skye Bioscience, Inc. | -13.54 Million USD | -162.213% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -2288.269% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -141993.58% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -814.533% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -123.844% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -1319.822% |
| GB Sciences, Inc. | -1.41 Million USD | -2401.85% |
| Alpha Cognition Inc. | -9.7 Million USD | -266.009% |
| HST Global, Inc. | -5303.00 USD | -669773.562% |
| CSL Limited | 4.78 Billion USD | 100.742% |
| Halberd Corporation | -74.27 Thousand USD | -47724.277% |
| Enzolytics Inc. | -2.12 Million USD | -1574.03% |
| Resverlogix Corp. | -11.74 Million USD | -202.533% |
| Affymax, Inc. | -14.29 Million USD | -148.502% |
| SYBLEU INC | -141.57 Thousand USD | -24992.282% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -1059.752% |
| argenx SE | -216.02 Million USD | 83.556% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 35.808% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 3018.931% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -2269.955% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 9476.787% |
| AVAX Technologies, Inc. | -6.11 Million USD | -481.146% |
| Zenith Capital Corp. | -8.6 Million USD | -312.775% |
| Genscript Biotech Corporation | -248.71 Million USD | 85.717% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -203811.343% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -1352.032% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -20080.954% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 10.378% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -1128.195% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -3295.105% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 528407.481% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -1929.909% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -1749.299% |
| BioStem Technologies, Inc. | -7.55 Million USD | -370.281% |
| ONE Bio Corp. | 13.61 Million USD | 360.951% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -19516.648% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -1626.952% |
| Agentix Corp. | -1.37 Million USD | -2489.629% |
| LadRx Corporation | 412.28 Thousand USD | 8716.265% |
| Cell Source, Inc. | -4.27 Million USD | -731.438% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -9573.574% |
| Regen BioPharma, Inc. | 1.46 Million USD | 2523.224% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -3691.39% |
| NovAccess Global Inc. | -1.03 Million USD | -3332.885% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 501.222% |
| Itoco Inc. | -1.86 Million USD | -1800.668% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -9257.619% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -3083.1% |
| Kadimastem Ltd | -2.62 Million USD | -1253.591% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -14754.023% |
| CytoDyn Inc. | -18.02 Million USD | -97.035% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -44849.822% |
| Mobile Lads Corp. | -2.24 Million USD | -1485.046% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -290384.872% |
| Qrons Inc. | -40.08 Thousand USD | -88529.014% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -7214.187% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 6835.148% |
| Rebus Holdings, Inc. | -951 Thousand USD | -3635.373% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -3244.921% |
| International Stem Cell Corporation | 202 Thousand USD | 17685.839% |
| Bioxytran, Inc. | -3.82 Million USD | -829.896% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -67383.653% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -1342.907% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 0.964% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -78840.878% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -1197.421% |
| Neutra Corp. | -181.24 Thousand USD | -19499.439% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -76.216% |
| PureTech Health plc | -11.62 Million USD | -205.525% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -76.228% |
| IXICO plc | -707 Thousand USD | -4924.525% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -362.243% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 26.523% |
| CSL Limited | 4.73 Billion USD | 100.751% |
| Cellectis S.A. | -92.63 Million USD | 61.653% |